Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caudal dexmedetomidine versus magnesium sulfate added to bupivacaine for pediatric infra-umbilical orthopedic surgery
PACTR201807487797587Phase 4Not yet recruiting
- Sponsor
- Kasr Al Ainy
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, magnesium sulfate and bupivacaine in postoperative pain (2 arms), sponsored by Kasr Al Ainy. Primary endpoint: Duration of bupivacaine caudal block. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
dexmedetomidinemagnesium sulfatebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR201807487797587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201807487797587.